Author:
Musorina A. S.,Turilova V. I.,Shatrova A. N.,Yakovleva T. K.,Poljanskaya G. G.
Reference64 articles.
1. Aksu, A., Rubin, J., Dudas, J., and Marra, K., Role of gender and anatomical region on induction of osteogenic differentiation of human adipose-derived stem cells, Ann. Plast. Surg., 2008, vol. 60, p. 306. https://doi.org/10.1097/SAP.0b013e3180621ff0
2. Antonucci, I., Stuppia, L., Kaneko, Y., Yu, S., Tajiri, N., Bae, E.C., Chheda, S.H., Weinbren, N.L., and Borlongan, C.V., Amniotic fluid as rich source of mesenchymal stromal cells for transplantation therapy, Cell Transplant., 2011, vol. 20, p. 789. https://doi.org/10.3727/096368910X539074
3. Barkholt, L., Flory, E., Jekerle, V., Lucas-Samuel, S., Ahnert, P., Bisset, L., Büscher, D., Fibbe, W., Foussat, A., Kwa, M., Lutz, O., Mačiulaitis, R., Palomäki, T., Schneider, C.K., Sensebé, L., Tachdjian, G., Tarte, K., Tosca, L., and Salmikangas, P. Risk of tumorigenicity in mesenchymal stromal cell-based therapies–bridging scientific observations and regulatory viewpoints. Cytother., 2013, vol. 15, p. 753. https://doi.org/10.1016/j.jcyt.2013.03.005
4. Benn, P.A. Specific chromosome aberrations in senescent fibroblast cell lines derived from human embryos, Am. J. Hum. Genet., 1976, vol. 28, p. 465.
5. Bongso, A. and Fong, C.Y., The therapeutic potential, challenges and future clinical directions of stem cells from the Wharton’s jelly of the human umbilical cord, Stem Cell Rev., 2013, vol. 9, p. 226. https://doi.org/10.1007/s12015-012-9418-z